Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-01-09 5:6:54 am | Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress | GlobeNewsWire |
| 2023-12-06 5:5:0 am | Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results | GlobeNewswire |
| 2023-11-13 5:5:0 am | CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan | GlobeNewswire |
| 2023-11-13 3:0:0 am | OVNO Continues Developing Breakthrough Treatments | Zacks Small Cap Research |
| 2023-11-11 4:11:46 am | Organovo Holdings Second Quarter 2024 Earnings: US$0.46 loss per share (vs US$0.38 loss in 2Q 2023) | Simply Wall St. |
| 2023-11-10 2:8:26 am | Organovo: Fiscal Q2 Earnings Snapshot | Associated Press Finance |
| 2023-11-08 5:5:0 am | Organovo Highlights FXR314 Combination Therapy Potential and Plan | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information